Anandamide, Cannabinoid Type 1 Receptor, and NMDA Receptor Activation Mediate Non-Hebbian Presynaptically Expressed Long-Term Depression at the First Central Synapse for Visceral Afferent Fibers.
Anandamide, Cannabinoid Type 1 Receptor, and NMDA Receptor Activation Mediate Non-Hebbian Presynaptically Expressed Long-Term Depression at the First Central Synapse for Visceral Afferent Fibers.
J Neurosci. 2013 Jul 31; 33(31): 12627-37
Khlaifia A, Farah H, Gackiere F, Tell F… Continue reading
Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-Based Care for the Treatment of Major Depressive Disorder.
Atypical Antipsychotic Augmentation Strategies in the Context of Guideline-based Care for the Treatment of Major Depressive Disorder.
CNS Drugs. 2013 May 25;
Patkar AA, Pae CU
There is a growing body of evidence that supports the use of atypical… Continue reading
Differences in Predictors of Traditional and Cyber-Bullying: A 2-Year Longitudinal Study in Korean School Children.
Differences in predictors of traditional and cyber-bullying: a 2-year longitudinal study in Korean school children.
Eur Child Adolesc Psychiatry. 2013 May; 22(5): 309-18
Yang SJ, Stewart R, Kim JM, Kim SW, Shin IS, Dewey ME, Maskey S, Yoon JS… Continue reading
Associated With Intrathecal Baclofen Treatment and Duloxetine in Patients With Multiple Sclerosis.
Associated with intrathecal baclofen treatment and duloxetine in patients with multiple sclerosis.
Int J Immunopathol Pharmacol. 2012 Jan-Mar; 25(1 Suppl): 51S-56S
Ranieri M, Putignano P, Fiore P, Santamato A, Megna G, Bellomo RG, Cristella G, Saggini R, Megna M… Continue reading
Amphetamine and Post-Stroke Rehabilitation: Indications and Controversies.
Amphetamine and post-stroke rehabilitation: indications and controversies.
Eur J Phys Rehabil Med. 2013 Apr 5;
Walker-Batson D
There is robust evidence for amphetamine (AMPH) facilitated recovery from behavioral deficits in animal models of stroke. Following experimental lesions, numerous studies… Continue reading